Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: Specific induction of enzyme expression in reactive astrocytes following brain injury
Michael Snyder, medical director of the Bariatric Surgery Center at Rose Medical Center and obesity specialist at FuturHealth
September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns FDA Major Stories The New York Times reported that the U.S
Symptoms and Warning Signs to Watch For Patients who start Foundayo should contact a clinician if they experience: Persistent nausea, vomiting, or severe abdominal pain Signs of low blood sugar if also taking diabetes medications Changes in vision Racing or pounding heartbeat Any new or unusual symptoms Rare but serious risks associated with GLP-1 medications include pancreatitis, gallbladder problems, and kidney injury related to dehydration from vomiting
Key Takeaways Itching can occur as a side effect of Rybelsus, though it's less common than digestive issues like nausea and diarrhea
Abstract Aims/hypothesis Concerns have been raised regarding a potential association of use of the incretin-based drugs dipeptidyl peptidase 4 (DPP4) inhibitors and glucagon-like peptide-1 (GLP-1)-receptor agonists with risk of cholangiocarcinoma